NS
ARKG icon

NBC Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

NBC Securities’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,000
Closed -$24K – 2777
2025
Q2 		$24K Sell
1,000
-375
-27% -$8.22K ﹤0.01% 1626
2025
Q1 		$28K Buy
1,375
+1,374
+137,400% +$34.5K ﹤0.01% 1345
2024
Q4 		$32 Sell
1
-1,624
-100% -$40K ﹤0.01% 1102
2024
Q3 		$41K Hold
1,625
– – ﹤0.01% 1230
2024
Q2 		$38K Hold
1,625
– – ﹤0.01% 1218
2024
Q1 		$46K Sell
1,625
-1,900
-54% -$57.1K ﹤0.01% 1155
2023
Q4 		$115K Buy
3,525
+423
+14% +$11.5K 0.01% 902
2023
Q3 		$86K Buy
+3,102
New +$101K 0.01% 980

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NBC Securities's ARKG Position: Q3 2025 in Review

NBC Securities sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2025, closing a stake of 1,000 shares — an estimated $24K sold.

NBC Securities first reported a position in ARKG in Q3 2023 and held it in 8 quarters. The position peaked at $115K in Q4 2023. 231 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.

  • NBC Securities reported no remaining ARK Genomic Revolution ETF position as of Q3 2025 after selling out during the quarter.
  • NBC Securities sold 1,000 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $24K.
  • NBC Securities first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 8 quarters.
  • NBC Securities's ARK Genomic Revolution ETF position peaked at $115K in Q4 2023.
  • 231 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.

Based on NBC Securities's 13F filing for Q3 2025, filed 14 Nov 2025.